Iyuzeh Solution/ Drops
Product Images NDC 82584-003

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Iyuzeh (NDC 82584-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Thea Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure (Figure1)

Chemical structure of Latanoprost, the active ingredient in IYUZEH Ophthalmic Solution 0.005%. The diagram displays the molecular formula with hydroxyl groups, a cyclopentane ring, ester and phenyl functionalities, and a molecular weight of 432.58.*

FDA Label Image

Figure A (Figure2)

An instructional illustration showing a hand holding a small plastic single-use vial, with three similar vials aligned in the background. The image likely depicts how to remove or prepare the ophthalmic solution drops for use.*

FDA Label Image

Figure A (Figure3)

A black and white line drawing illustrating the twisting motion to open a small ophthalmic solution bottle with a twist-off cap. The image shows circular arrows around the cap indicating the direction to twist for opening.*

FDA Label Image

Figure A (Figure4)

An instructional illustration showing the proper method to instill ophthalmic drops. The image depicts a hand holding a dropper above a person's eye, with the lower eyelid gently pulled down to create a small pocket for the drops to be administered accurately.*

FDA Label Image

Figure A (Figure5)

FDA Label Image

Carton (Figure6)

Packaging label for IYUZEH 0.005% (latanoprost ophthalmic solution) by Thea Pharma Inc. The label indicates 30 single-dose containers (0.2 mL each) of sterile, preservative-free ophthalmic solution for topical use. The label includes the NDC 82584-003-30 and directions for recommended dosage as one drop daily in the evening in the affected eye(s).*

FDA Label Image

Carton (Figure7)

Label for IYUZEH (latanoprost ophthalmic solution) 0.005% topical ophthalmic drops, containing 5 single-dose containers of 0.2 mL each. The label states the product is Rx only, sterile and preservative-free. Manufactured for Thea Pharma Inc., Lexington, MA. Includes dosage instructions and storage information.*

FDA Label Image

Carton (Figure8)

Packaging label for IYUZEH 0.005% (latanoprost ophthalmic solution), a sterile ophthalmic solution with no preservatives. The label indicates it contains 30 single-dose containers (0.2 mL each) for topical ophthalmic use. Manufactured by Thea Pharma Inc., the label includes dosage instructions and sample not for resale markings.*

FDA Label Image

Carton (Figure9)

Label for IYUZEH (latanoprost ophthalmic solution) 0.005%, a topical ophthalmic solution in 5 single-dose containers of 0.2 mL each. Manufactured for Thea Pharma Inc., Lexington, MA. The label notes the product is sterile, preservative-free, for prescription use, and includes dosage and storage instructions. This is a sample not for resale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.